Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shyrie C Edmonson"'
Autor:
Daniel J Hui, Shyrie C Edmonson, Gregory M Podsakoff, Gary C Pien, Lacramioara Ivanciu, Rodney M Camire, Hildegund Ertl, Federico Mingozzi, Katherine A High, Etiena Basner-Tschakarjan
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
Adeno-associated virus (AAV) has become one of the most promising vectors in gene transfer in the last 10 years with successful translation to clinical trials in humans and even market approval for a first gene therapy product in Europe. Administrati
Externí odkaz:
https://doaj.org/article/c3c459a322e749a9b9b077cc70a13749
Autor:
Yifeng Chen, F Mingozzi, Shyrie C Edmonson, Margriet J. Vervoordeldonk, Rogier M. Thurlings, Katherine A. High, Paul P. Tak, Shangzhen Zhou
Publikováno v:
Gene therapy, 20(4), 417-424. Nature Publishing Group
Gene Therapy
Gene Therapy
Antibodies against adeno-associated viral (AAV) vectors are highly prevalent in humans. Both preclinical and clinical studies showed that antibodies against AAV block transduction even at low titers, particularly when the vector is introduced into th
Autor:
Cynthia E. Dunbar, Katherine A. High, Shyrie C Edmonson, Robert E. Donahue, Alex Tai, Mark E. Metzger, J. Fraser Wright, Shangzhen Zhou, Yifeng Chen, Sandra D. Price, Federico Mingozzi, Samuel L. Murphy
Publikováno v:
Molecular Therapy
Liver gene transfer for hemophilia B has shown very promising results in recent clinical studies. A potential complication of gene-based treatments for hemophilia and other inherited disorders, however, is the development of neutralizing antibodies (
Autor:
Federico Mingozzi, Daniel J. Hui, Hildegund C.J. Ertl, Shyrie C Edmonson, Rodney M. Camire, Etiena Basner-Tschakarjan, Lacramioara Ivanciu, Katherine A. High, Gregory M. Podsakoff, Gary C. Pien
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss, Pp-(2015)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Adeno-associated virus (AAV) has become one of the most promising vectors in gene transfer in the last 10 years with successful translation to clinical trials in humans and even market approval for a first gene therapy product in Europe. Administrati